NCT03823404: GAIN Trial: Phase 2/3 Study of COR388 in Subjects With Alzheimer's Disease
- State
- Completed
- Phase
- Phase 2 and Phase 3
- People
- 643 taking part
- Started
- 28 Mar 2019
- Primary completion
- 1 Jan 2022
- Arms
- COR388 80 mg twice daily (BID), COR388 40 mg BID
- Results
- Posted on the registry
- 30 Jan 2019: Trial registered
- 28 Mar 2019: Trial started
- 1 Jan 2022: Trial completed
- 23 Feb 2023: Trial results posted